Navigation Links
Queen's University Belfast lung injury study could save lives in critically ill
Date:10/13/2010

Researchers at Queen's University Belfast are investigating a potential new treatment for lung disease that could save many lives each year.

The research team is studying how statins, drugs which are commonly used to treat high cholesterol, can be used to treat lung disease.

There is currently no effective treatment for acute lung injury. The team hopes the work could boost survival rates for those who become critically ill and suffer lung failure after incidents such as road traffic accidents or severe infections.

Leading the research is Professor Danny McAuley from Queen's Centre for Infection and Immunity. He said: "When people are critically ill their lungs can fail. This is termed 'acute lung injury' and means that the lungs fill with water instead of air. Breathing becomes difficult and a ventilator is needed to take over.

"Statins have the potential to improve lung injury by reducing inflammation in the lung, reversing the damage and therefore decreasing the amount of water in the lungs. This helps fight infection."

The team includes Queen's researchers, Dr Celia O'Kane and Professor Cliff Taggart, along with Professor John Laffey from National University Ireland, Galway.

The research has the potential to free up healthcare resources and allow more people to return to the workplace sooner following spells in hospital.

Professor McAuley added: "There may be up to 45,000 cases of acute lung injury each year in the UK and Ireland and up to 22,000 deaths. Only around half of those who survive are able to return to work 12 months after discharge from hospital. After recovery from lung injury, patients can go on to experience a poorer quality of life and many are unable to look after themselves.

"But this treatment has the potential to reduce the impact of acute lung injury and the time patients need to stay in intensive care units. It could also significantly reduce the strain on hospital beds."

The study is being managed by staff from the Clinical Research Support Centre in the Belfast Health and Social Care Trust and has been supported by the infrastructure provided by the Northern Ireland Clinical Research Network. The Clinical Research Facility at NUI Galway is providing additional support. The study is taking place over four years in approximately 25 other intensive care units throughout the UK and Ireland.


'/>"/>

Contact: Donna McCullough
comms.office@qub.ac.uk
44-289-097-5391
Queen's University Belfast
Source:Eurekalert

Related biology news :

1. Unlike us, honeybees naturally make quick switch in their biological clocks, says Hebrew University researcher
2. University of Utah microbubbles clean dirty soil in China
3. Ben-Gurion University of the Negev hosts UNESCO conference on drylands, deserts and desertification
4. Brown University chemists simplify biodiesel conversion
5. New fisheries system will save about $20 million, Iowa State University researchers find
6. Hebrew University research holds promise for development of new osteoporosis drug
7. Auxogyn licenses noninvasive embryo assessment technology from Stanford University
8. Iowa State University researcher examines mosquito gene for new disease response
9. WSJ honors university-created LLC with Innovation Award
10. University of Nevada, Reno, demonstrates successful sludge-to-power research
11. University of Nevada, Reno demonstrates successful sludge-to-power research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016  The Office ... today published "Can CT Scans Enhance or Replace ... the potential of supporting or replacing forensic autopsies ... CT scan. In response to recommendations ... is exploring using CT scans as a potential ...
(Date:11/29/2016)... BOSTON , Nov. 29, 2016 BioDirection, ... rapid point-of-care products for the objective detection of concussion ... the company has successfully completed a meeting with the ... company,s Tbit™ blood test Pre-Submission Package. During the meeting ... Tbit™ system as a precursor to commencement of a ...
(Date:11/22/2016)... According to the new market research report "Biometric ... Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, ... is expected to grow from USD 10.74 Billion in 2015 to reach ... and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Eutilex Co. Ltd. today announced that it ... A financing. This financing round included participation from DS ... Bio Angel. This new funding brings the total capital ... since its founding in 2015. The ... commercialization of its immuno-oncology programs, expand its R&D capabilities ...
(Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selector™ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
(Date:12/7/2016)... ... 2016 , ... A new study published in the just-published ... advanced pancreatic cancer, liquid biopsies are not yet an adequate substitute for tissue ... sampling may improve the value of a blood-based test.” The study was conducted ...
(Date:12/7/2016)... , Dec. 7, 2016 Neogen Corporation (NASDAQ: ... Dr. Dan Kephart as its chief science ... will assume his responsibilities at Neogen effective Jan. 1. ... director for the agribusiness unit of Thermo Fisher Scientific, ... at Life Technologies. His extensive industry experience also includes ...
Breaking Biology Technology: